ATAI
Price
$1.18
Change
-$0.14 (-10.61%)
Updated
Dec 18 closing price
98 days until earnings call
OCGN
Price
$0.75
Change
-$0.08 (-9.64%)
Updated
Dec 18 closing price
99 days until earnings call
Ad is loading...

ATAI vs OCGN

Header iconATAI vs OCGN Comparison
Open Charts ATAI vs OCGNBanner chart's image
ATAI Life Sciences
Price$1.18
Change-$0.14 (-10.61%)
Volume$1.59M
CapitalizationN/A
Ocugen
Price$0.75
Change-$0.08 (-9.64%)
Volume$9.15M
CapitalizationN/A
ATAI vs OCGN Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. OCGN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and OCGN is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ATAI: $1.18 vs. OCGN: $0.75)
Brand notoriety: ATAI and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 101% vs. OCGN: 233%
Market capitalization -- ATAI: $221.5M vs. OCGN: $242.41M
ATAI [@Biotechnology] is valued at $221.5M. OCGN’s [@Biotechnology] market capitalization is $242.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than OCGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 5 TA indicator(s) are bullish while OCGN’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 5 bullish, 4 bearish.
  • OCGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than OCGN.

Price Growth

ATAI (@Biotechnology) experienced а -20.27% price change this week, while OCGN (@Biotechnology) price change was -13.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.34%. For the same industry, the average monthly price growth was -2.43%, and the average quarterly price growth was +0.77%.

Reported Earning Dates

ATAI is expected to report earnings on Mar 27, 2025.

OCGN is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (-4.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCGN($242M) has a higher market cap than ATAI($221M). OCGN YTD gains are higher at: 31.217 vs. ATAI (-16.312). OCGN has higher annual earnings (EBITDA): -50.89M vs. ATAI (-124.33M). ATAI has more cash in the bank: 85.9M vs. OCGN (38.7M). OCGN has less debt than ATAI: OCGN (6.78M) vs ATAI (23.8M). OCGN has higher revenues than ATAI: OCGN (4.7M) vs ATAI (331K).
ATAIOCGNATAI / OCGN
Capitalization221M242M91%
EBITDA-124.33M-50.89M244%
Gain YTD-16.31231.217-52%
P/E RatioN/AN/A-
Revenue331K4.7M7%
Total Cash85.9M38.7M222%
Total Debt23.8M6.78M351%
FUNDAMENTALS RATINGS
ATAI vs OCGN: Fundamental Ratings
ATAI
OCGN
OUTLOOK RATING
1..100
7455
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6158
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCGN's Valuation (60) in the null industry is in the same range as ATAI (78) in the Miscellaneous Commercial Services industry. This means that OCGN’s stock grew similarly to ATAI’s over the last 12 months.

OCGN's Profit vs Risk Rating (94) in the null industry is in the same range as ATAI (100) in the Miscellaneous Commercial Services industry. This means that OCGN’s stock grew similarly to ATAI’s over the last 12 months.

OCGN's SMR Rating (98) in the null industry is in the same range as ATAI (98) in the Miscellaneous Commercial Services industry. This means that OCGN’s stock grew similarly to ATAI’s over the last 12 months.

OCGN's Price Growth Rating (58) in the null industry is in the same range as ATAI (61) in the Miscellaneous Commercial Services industry. This means that OCGN’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's P/E Growth Rating (14) in the Miscellaneous Commercial Services industry is significantly better than the same rating for OCGN (100) in the null industry. This means that ATAI’s stock grew significantly faster than OCGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIOCGN
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMIEX12.50N/A
N/A
Northern Active M International Equity
GSPRX30.34N/A
N/A
Goldman Sachs Large Cap Core R
MAIHX15.50-0.38
-2.39%
Morgan Stanley Inst Passport ovrs eq IR
VSNGX63.52-2.17
-3.30%
JPMorgan Mid Cap Equity I
RYVCX170.54-6.46
-3.65%
Rydex Energy Services C

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with FATE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-10.61%
FATE - ATAI
48%
Loosely correlated
-10.37%
ALLO - ATAI
45%
Loosely correlated
-7.97%
COUR - ATAI
45%
Loosely correlated
-4.07%
VCYT - ATAI
45%
Loosely correlated
-6.42%
MNMD - ATAI
44%
Loosely correlated
-3.41%
More

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with ARRY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-9.33%
ARRY - OCGN
47%
Loosely correlated
-1.65%
AXON - OCGN
46%
Loosely correlated
-4.06%
XNCR - OCGN
35%
Loosely correlated
-5.23%
ATAI - OCGN
35%
Loosely correlated
-10.61%
ATOS - OCGN
34%
Loosely correlated
-4.81%
More